Rabigen SAG2

Riik: Euroopa Liit

keel: inglise

Allikas: EMA (European Medicines Agency)

Osta kohe

Infovoldik Infovoldik (PIL)
06-11-2018
Toote omadused Toote omadused (SPC)
06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
21-07-2013

Toimeaine:

live attenuated rabies virus, SAG2 strain

Saadav alates:

Virbac S.A.

ATC kood:

QI07AA02

INN (Rahvusvaheline Nimetus):

live vaccine against rabies

Terapeutiline rühm:

Raccoon dogs (Nyctereutes procyonoides); Red foxes (Vulpes vulpes)

Terapeutiline ala:

Live viral vaccines

Näidustused:

For the active immunisation of red foxes and raccoon dogs to prevent infection by rabies virus.The duration of protection is of at least 6 months.

Toote kokkuvõte:

Revision: 9

Volitamisolek:

Authorised

Loa andmise kuupäev:

2000-04-06

Infovoldik

                                11
-
20 baits per square km over the areas where fox / raccoon dog density
indexes were more than 3
foxes / raccoon dogs seen per 10 km.
Read the package leaflet before use.
8.
SPECIAL WARNINGS, IF NECESSARY
It is recommended to wear rubber gloves.
People handling and distributing this vaccine should be vaccinated
against rabies.
Immunocompromised/immunosuppressed individuals must not be allowed to
handle this vaccine.
In the event of human exposure to the active ingredient of the
vaccine, seek medical advice
immediately and show the package leaflet i or the label to the
physician.
No adverse events have been reported in the target species.
As this vaccine presentation contains traces of gentamicin and
contains tetracycline as biomarker,
occasional hypersensitivity reactions may be observed in domestic
animals that have accidentally
ingested the bait.
Vomiting due to gastric intolerance (potentially due to the
aluminium/PVC sachet as part of the bait
vaccine), in dogs which have accidentally ingested the bait, has been
reported.
9.
EXPIRY DATE
EXP : {month/year}
10.
SPECIAL STORAGE CONDITIONS
Store in a freezer at -40°C to -20°C.
Protect from light. Keep the boxes tightly closed.
11.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR
WASTE MATERIALS, IF ANY
Dispose of waste material and any unplaced baits at the end of the day
of distribution by boiling or
incineration or immersion in an appropriate disinfectant approved for
use by the competent authorities.
12.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR
RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
For animal treatment only - to be supplied only on veterinary
prescription.
Restricted to duly designated competent administrative authorities.
The import, sale, supply and/or use of this veterinary medicinal
product is or may be prohibited in
certain
Member
States
on
the
whole
or
part
of
their
territory,
see
package
insert
for
further
information.
13.
THE WORDS “KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”
Keep out of the reach a
                                
                                Lugege kogu dokumenti
                                
                            

Toote omadused

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rabigen SAG2 oral suspension, for red foxes and raccoon dogs.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE :
Live attenuated rabies virus, SAG2 strain
minimum 8 log10 CCID50*/dose
* CCID50 : Cell Culture Infective Dose 50%
EXCIPIENTS :
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Red foxes (_Vulpes vulpes_) and raccoon dogs (_Nyctereutes
procyonoides_).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of red foxes and raccoon dogs to prevent
infection by rabies virus.
The duration of protection is of at least 6 months.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Not applicable.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Baits shall not be distributed in inhabited areas, roads and watery
areas.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
It is recommended to wear rubber gloves.
People handling and distributing this vaccine should be vaccinated
against rabies.
Immunocompromised/immunosuppressed individuals must not be allowed to
handle this vaccine.
In the event of human exposure to the active ingredient of the
vaccine, seek medical advice
immediately and show the package leaflet or the label to the
physician.
3
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
No adverse events have been reported in the target species.
As this vaccine presentation contains traces of gentamicin and
contains tetracycline as biomarker,
occasional hypersensitivity reactions may be observed in domestic
animals that have accidentally
ingested the bait.
Vomiting due to gastric intolerance (potentially due to the
aluminium/PVC sachet as part of the bait
vaccine), in dogs which have accidentally ingested the bait, has been
reported.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
The safety of the vaccine in
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik bulgaaria 06-11-2018
Toote omadused Toote omadused bulgaaria 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande bulgaaria 21-07-2013
Infovoldik Infovoldik hispaania 06-11-2018
Toote omadused Toote omadused hispaania 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande hispaania 21-07-2013
Infovoldik Infovoldik tšehhi 06-11-2018
Toote omadused Toote omadused tšehhi 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande tšehhi 21-07-2013
Infovoldik Infovoldik taani 06-11-2018
Toote omadused Toote omadused taani 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande taani 21-07-2013
Infovoldik Infovoldik saksa 06-11-2018
Toote omadused Toote omadused saksa 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande saksa 21-07-2013
Infovoldik Infovoldik eesti 06-11-2018
Toote omadused Toote omadused eesti 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande eesti 21-07-2013
Infovoldik Infovoldik kreeka 06-11-2018
Toote omadused Toote omadused kreeka 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande kreeka 21-07-2013
Infovoldik Infovoldik prantsuse 06-11-2018
Toote omadused Toote omadused prantsuse 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande prantsuse 21-07-2013
Infovoldik Infovoldik itaalia 06-11-2018
Toote omadused Toote omadused itaalia 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande itaalia 21-07-2013
Infovoldik Infovoldik läti 06-11-2018
Toote omadused Toote omadused läti 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande läti 21-07-2013
Infovoldik Infovoldik leedu 06-11-2018
Toote omadused Toote omadused leedu 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande leedu 21-07-2013
Infovoldik Infovoldik ungari 06-11-2018
Toote omadused Toote omadused ungari 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande ungari 21-07-2013
Infovoldik Infovoldik malta 06-11-2018
Toote omadused Toote omadused malta 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande malta 21-07-2013
Infovoldik Infovoldik hollandi 06-11-2018
Toote omadused Toote omadused hollandi 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande hollandi 21-07-2013
Infovoldik Infovoldik poola 06-11-2018
Toote omadused Toote omadused poola 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande poola 21-07-2013
Infovoldik Infovoldik portugali 06-11-2018
Toote omadused Toote omadused portugali 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande portugali 21-07-2013
Infovoldik Infovoldik rumeenia 06-11-2018
Toote omadused Toote omadused rumeenia 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande rumeenia 21-07-2013
Infovoldik Infovoldik slovaki 06-11-2018
Toote omadused Toote omadused slovaki 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande slovaki 21-07-2013
Infovoldik Infovoldik sloveeni 06-11-2018
Toote omadused Toote omadused sloveeni 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande sloveeni 21-07-2013
Infovoldik Infovoldik soome 06-11-2018
Toote omadused Toote omadused soome 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande soome 21-07-2013
Infovoldik Infovoldik rootsi 06-11-2018
Toote omadused Toote omadused rootsi 06-11-2018
Avaliku hindamisaruande Avaliku hindamisaruande rootsi 21-07-2013
Infovoldik Infovoldik norra 06-11-2018
Toote omadused Toote omadused norra 06-11-2018
Infovoldik Infovoldik islandi 06-11-2018
Toote omadused Toote omadused islandi 06-11-2018
Infovoldik Infovoldik horvaadi 06-11-2018
Toote omadused Toote omadused horvaadi 06-11-2018

Vaadake dokumentide ajalugu